
Founded in 2001, Title21 is a healthcare software company dedicated to digitizing complex, highly regulated workflows in cell and gene therapy (CGT) and advanced therapies. Its platforms replace manual, paper-based processes with integrated digital solutions spanning manufacturing, quality, compliance, and patient delivery. Since 2022, Title21 is backed by ARCHIMED.
As part of its European expansion, Title21 has acquired MyCellHub, a Belgium-based SaaS company serving biotech and CGT players operating under GMP and GxP constraints. Belgium is now Title21’s European operational hub.
To support this ambition, we are hiring a Vice President Sales Europe & Middle East to own regional commercial growth and build a scalable, high-performing sales organization.
This is a hands-on builder role combining strategy, execution, and leadership in a complex, regulated SaaS environment.
Reporting to the Chief Commercial Officer, the VP Sales Europe & Middle East will be fully accountable for revenue growth, customer relationships, and sales execution across the region.
Key responsibilities include:
Requirements
We are looking for a senior, hands-on commercial leader with:

With offices in Europe, North America and APAC, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritized areas of focus include Biopharma Products, Consumer Health, Animal & Environmental Health, Healthcare IT, Diagnostics, Life Science Tools & Biologic Services, MedTech, and Pharma Services. ARCHIMED helps partners internationalize, acquire, innovate and expand their products and services.
ARCHIMED manages €9 billion across its various funds, including the largest healthcare-only private equity fund raised by a European-based General Partner.
Since inception, ARCHIMED has been a committed Impact investor, both directly and through its EURÊKA Foundation.